Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > TODAY’S NUMBERS
View:
Post by Revten on Apr 03, 2024 4:25pm

TODAY’S NUMBERS

House Positions for C:EDT from 20240403 to 20240403
House Bought $Val Ave Sold $Val Ave Net $Net
7 TD Sec 34,000 14,712 0.433 0   34,000 -14,712
2 RBC 11,500 5,032 0.438 2,224 974 0.438 9,276 -4,058
85 Scotia 6,000 2,550 0.425 0   6,000 -2,550
1 Anonymous 7,924 3,466 0.437 6,500 2,862 0.44 1,424 -604
79 CIBC 3,500 1,522 0.435 2,500 1,100 0.44 1,000 -422
124 Questrade 0   200 87 0.435 -200 87
88 Credential 0   500 217 0.434 -500 217
9 BMO Nesbitt 0   1,000 435 0.435 -1,000 435
53 Morgan Stanley 0   50,000 21,607 0.432 -50,000 21,607
TOTAL 62,924 27,282 0.434 62,924 27,282 0.434 0 0

 

Do I See Morgan Stanley On The Sell??

63K Total on the day and MS represented 50K.....??

Love it! :)

BUY BUY BUY

Cheers!

Be the first to comment on this post